Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well rosiglitazone works in preventing oral cancer in
patients with oral leukoplakia. Chemoprevention is the use of certain drugs to keep cancer
from forming, growing, or coming back. The use of rosiglitazone may keep cancer from forming
in patients with oral leukoplakia